Bariatric surgery reduces long-term risk of diabetes by over 80 % among people with obesity

Bariatric surgery reduces the long-term risk of developing diabetes by over 80 % among people with obesity. The New England Journal of Medicine (NEJM) has published the results of a study conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.

A study conducted by Professor Lars Sj-str-m, Professor Lena Carlsson and their team at Sahlgrenska Academy, University of Gothenburg, has found that bariatric surgery is considerably more effective than traditional care and lifestyle changes in preventing diabetes among people with obesity.

The treatment group consisted of 1,658 subjects who had undergone bariatric surgery, while the control group consisted of 1,771 equally obese people who had received traditional care. During 15-year follow-up, 392 people in the control group and only 110 people in the treatment group developed diabetes.

"Our results show that bariatric surgery can reduce the risk of developing diabetes by more than 80 %", Professor Sj-str-m says. "This is an extremely high figure."

The study is based on an extensive study entitled Swedish Obese Subjects (SOS), which has given rise to more than 90 scientific articles and demonstrated that bariatric surgery is also highly beneficial when it comes to cancer, cardiovascular disease, total mortality and health-related quality of life.

"Both women and men benefited in terms of diabetes", Professor Sj-str-m says, "but the degree of obesity at baseline did not affect the results."

Source: University of Gothenburg

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes rates skyrocket globally with millions left untreated